Related Experiment Video
Updated: Jun 23, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Anticoagulation in the octogenarian with atrial fibrillation
1Rhode Island Hospital, USA.
Abstract:
BI's baseline annual risk of stroke was 12.5% by CHADS2 score; her 5-year stroke risk by the Framingham tool was 59%. Risk factors for bleeding included diabetes, aspirin use and ibuprofen use, and a moderate fall risk by physical therapy assessment due to her osteoarthritis and deconditioned state. Given her fall risk, she and her family decided against anticoagulation with warfarin. She was discharged to an acute rehabilitation facility on aspirin alone. The decision to utilize warfarin for anticoagulation in the elderly patient with AF remains an art, involving judicious use of tools to evaluate baseline risk of stroke, careful evaluation for risk factors for bleeding, and diligent consideration of the patient, and his or her comorbidities, medications and ability to comply with treatment and monitoring.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug Dosing: Geriatric Patients
